Modified or specialty blood components may be useful in specific clinical settings to reduce the risk of transfusion-related harm. Specialty blood products available to physicians include CMV-seronegative, irradiated, and washed red blood cells or platelets. This chapter describes the preparation of these blood components and the clinical setting in which they are of greatest benefit.
This first chapter of the Clinical Guide to Transfusion provides an overview of the blood system in Canada, the regulations and standards that are in place and the organizations and professionals that, together, ensure transfusion medicine safety for Canadian patients.
In the delicate balance between clotting and bleeding, current laboratory research being undertaken by our partners is evolving our knowledge of how anticoagulant drugs work
This primer is part I of our new series exploring the future of blood banking. Given that D is also for Development: Canadian Blood Services and the Centre for Innovation have been following the development of pathogen inactivation technologies and how they can be used to improve safety. Read-on to learn more about these technologies and their potential to shift the blood safety paradigm.
